Elysar Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ambala City, Haryana, India, established in 2020.
2020 Ambala City, Haryana, India Active
Last Updated:
Access Report
About Elysar Pharmaceuticals Private Limited

Elysar Pharmaceuticals Private Limited, a active private limited company, was established on 09 June 2020 in Ambala City, Haryana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299HR2020PTC086670. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Neena Bajaj (Director), Nisha Bajaj (Director). Its latest AGM occurred on 14 August 2025, with the balance sheet filed on 31 March 2025. It is based at House No. 1885/10 Ranjeet Nagar, Ambala City, Haryana, 134003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299HR2020PTC086670

  • Registration Number

    086670

  • Incorporation Date

    09 June 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -3.37%
  • Ebitda ****
  • Net Worth -4.54%
  • Total Assets -4.38%
Company report

Elysar Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elysar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Elysar Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Neena Bajaj Director 09 Jun 2020 Current
Nisha Bajaj Director 09 Jun 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elysar Pharmaceuticals.

Elysar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.37% decrease in profit. The company's net worth dipped by a decrease of 4.54%.

Elysar Pharmaceuticals revenue growth over time
Elysar Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -4.38%
*******
*******
*******
*******
Profit or Loss
*******
 -3.37%
*******
*******
*******
*******
Net Worth
*******
 -4.54%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elysar Pharmaceuticals?

Unlock access to Elysar Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Elysar Pharmaceuticals?

Unlock and access historical data on people associated with Elysar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elysar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elysar Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elysar Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Elysar Pharmaceuticals Private Limited last Annual general meeting of members was held on 14 Aug 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Elysar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Director Appointment

    The activity Neena Bajaj was appointed as a Director was appointed as a Director on 09 Jun 2020 & has been associated with this company since 5 years 8 months . was completed.

  • Director Appointment

    Progress on Nisha Bajaj was appointed as a Director was appointed as a Director on 09 Jun 2020 & has been associated with this company since 5 years 8 months . was documented.

  • Company Incorporation

    Elysar Pharmaceuticals Private Limited was registered on 09 Jun 2020 with Roc Delhi & aged 5 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elysar Pharmaceuticals Private Limited?

The CIN of Elysar Pharmaceuticals Private Limited is U24299HR2020PTC086670.

Where is Elysar Pharmaceuticals Private Limited headquartered?

Elysar Pharmaceuticals Private Limited is headquartered at House No. 1885/10 Ranjeet Nagar, Ambala City, Haryana, 134003.

When was Elysar Pharmaceuticals Private Limited incorporated?

Elysar Pharmaceuticals Private Limited was incorporated on 09 June 2020.

Who are the current directors of Elysar Pharmaceuticals Private Limited?

The current directors of Elysar Pharmaceuticals Private Limited are

What is the primary industry of Elysar Pharmaceuticals Private Limited?

The primary industry of Elysar Pharmaceuticals Private Limited is Pharma.

Is Elysar Pharmaceuticals Private Limited a listed company?

Elysar Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Elysar Pharmaceuticals Private Limited?

The authorized capital of Elysar Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available